A1707 (2023-24 session)
NY State bill
Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
- Title
- Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
- Type
- New York State Assembly bill
- Session
- 2023-24 session
- Status
- Signed by Governor
- Latest action date
- 2023-12-22
- Introduced
- 2023-01-18
- Active version
- A1707A
- Same as
- S599
- Law section
- Insurance Law
Sponsors
Co-sponsors
Heard in committee
Same as
- S599 (2023-24 session) NY State bill
Substituted for
- S599 (2023-24 session) NY State bill